BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. cell-cell adhesion, Lung cancer, Stem cell, Laryngoscope, Doxycycline, rs2300478, PBX1)
Bookmark Forward

QuickView for epo protein, human (compound)


Genetic Markers

Most Correlated Genes

  1. TRIB3
  2. DDIT3
  3. CCNG2
  4. GJA1
  5. ARMCX2
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. PILON_KLF1_TARGETS_DN
  2. LEE_BMP2_TARGETS_DN
  3. KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
  4. KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
  5. GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Breast tumor initiating (CD44+ CD24- EPCAM+) cells treated with erythropoietin (EPO)
  2. Erythroblast gene expression at distinct stages of in vitro maturation
  3. CFU-E stage progenitor cells treated with erythropoietin
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The transcriptional and regulatory identity of erythropoietin producing cells.
  2. Serum erythropoietin in acute ischemic stroke: preliminary findings.
  3. Could an acute respiratory distress syndrome in COVID-19 infected patients be calmed down simply by …
  4. Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with e…
  5. EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control S…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation
  2. Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
  3. Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475
  4. Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants
  5. Renal Effects of Erythropoietin in Humans
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.